Literature DB >> 2289969

A critique of current diagnostic criteria for attention deficit hyperactivity disorder: clinical and research implications.

R A Barkley1.   

Abstract

The present paper critiques the current diagnostic criteria from the DSM-III-R and the draft criteria proposed for the ICD-10 for attention deficit hyperactivity disorder (ADHD). Improvements made in the criteria over earlier editions are discussed along with continuing limitations in these approaches to clinical diagnosis. The issue of whether ADHD constitutes an actual syndrome is also reviewed. It is concluded that despite contradictory evidence for covariation of the symptoms, the disorder meets other important conditions for syndrome definition and should continue to be viewed as such. The variability of symptoms across settings and parameters which may affect this variability are briefly noted as is the impact of this symptom instability on establishing diagnostic criteria. A number of suggestions for revision of these criteria are provided that can be incorporated into current clinical and research practices to improve the rigor and discriminative validity of the criteria for ADHD. The implications of these revisions for clinical diagnosis are also discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2289969

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  21 in total

1.  A comparison of behavioral and attentional functioning in children diagnosed as hyperactive or learning-disabled.

Authors:  P M Robins
Journal:  J Abnorm Child Psychol       Date:  1992-02

Review 2.  Interventions to address the academic impairment of children and adolescents with ADHD.

Authors:  Veronica L Raggi; Andrea M Chronis
Journal:  Clin Child Fam Psychol Rev       Date:  2006-06

3.  Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions.

Authors:  Maria T Acosta; F Xavier Castellanos; Kelly L Bolton; Joan Z Balog; Patricia Eagen; Linda Nee; Janet Jones; Luis Palacio; Christopher Sarampote; Heather F Russell; Kate Berg; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-07       Impact factor: 8.829

Review 4.  Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?

Authors:  Torri W Miller; Joel T Nigg; Robin L Miller
Journal:  Clin Psychol Rev       Date:  2008-10-11

5.  Predicting ADHD Symptoms in Adolescence from Early Childhood Temperament Traits.

Authors:  Tzlil Einziger; Linoy Levi; Yael Zilberman-Hayun; Judith G Auerbach; Naama Atzaba-Poria; Shoshana Arbelle; Andrea Berger
Journal:  J Abnorm Child Psychol       Date:  2018-02

Review 6.  Animal models to guide clinical drug development in ADHD: lost in translation?

Authors:  Jeffery R Wickens; Brian I Hyland; Gail Tripp
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  Change over time in adolescent and friend alcohol use: Differential associations for youth with and without childhood attention-deficit/hyperactivity disorder (ADHD).

Authors:  Katherine A Belendiuk; Sarah L Pedersen; Kevin M King; William E Pelham; Brooke S G Molina
Journal:  Psychol Addict Behav       Date:  2015-10-05

8.  Attention on inattention: the differential effect of caregiver education on endorsement of ADHD symptoms.

Authors:  Jill Weckerly; Gregory A Aarons; Laurel K Leslie; Ann F Garland; John Landsverk; Richard L Hough
Journal:  J Dev Behav Pediatr       Date:  2005-06       Impact factor: 2.225

9.  Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder.

Authors:  Evgeniy Perlov; Alexandra Philipsen; Ludger Tebartz van Elst; Dieter Ebert; Juergen Henning; Simon Maier; Emanuel Bubl; Bernd Hesslinger
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

Review 10.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.